LZTS2 抗体
Quick Overview for LZTS2 抗体 (ABIN7115825)
抗原
See all LZTS2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- LZTS2 antibody
-
纯化方法
- Immunogen affinity purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- leucine zipper, putative tumor suppressor 2
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months
-
有效期
- 12 months
-
-
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
别名
- LZTS2
-
背景
-
Synonyms: Leucine zipper putative tumor suppressor 2 (hLZTS2)|Protein LAPSER1|LZTS2|KIAA1813|LAPSER1
Background: Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.
-
分子量
- 70-80 kDa
-
基因ID
- 84445
-
UniProt
- Q9BRK4
抗原
-